CHICAGO, January 27, 2026--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced results from a new study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results